World's Best Scientists 2026 revealed!
Ravichandran Ramasamy

Ravichandran Ramasamy

D-Index & Metrics

Medicine

D-Index
72
Citations
19218
World Ranking
19830
National Ranking
9879

Overview

Ravichandran Ramasamy is affiliated with New York University in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to subfields including Physiology, Clinical Biochemistry, Cell Biology, Molecular Biology, and Endocrinology, Diabetes and Metabolism.

Their work addresses a spectrum of topics related to metabolic and cardiovascular health. Major areas of research include Advanced Glycation End Products, Aldose Reductase and Taurine, Adipokines and inflammation in metabolic diseases, Adipose Tissue metabolism, Adenosine and Purinergic Signaling, COVID-19 clinical research, and the roles of Heme Oxygenase-1 and Carbon Monoxide.

Ramasamy's recent publications demonstrate this focus with studies published in various scientific journals. Notable papers include:

  • Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models, 2020, Frontiers in Cardiovascular Medicine
  • Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications, 2021, Frontiers in Endocrinology
  • Enhanced glycolysis and HIF-1α activation in adipose tissue macrophages sustains local and systemic interleukin-1β production in obesity, 2020, Scientific Reports
  • RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism, 2020, JCI Insight
  • COVID-19 and the Heart and Vasculature, 2020, Arteriosclerosis Thrombosis and Vascular Biology

They have frequently published in notable venues such as Arteriosclerosis Thrombosis and Vascular Biology, Circulation, Circulation Research, Diabetes, and Cardiovascular Research. The counts of publications in these journals reflect an ongoing engagement with cardiovascular and metabolic disease topics.

Collaboration has been a consistent element of Ramasamy's research, often working alongside frequent coauthors including Ann Marie Schmidt, Gautham Yepuri, Lakshmi Arivazhagan, Riccardo Perfetti, and Henry H. Ruiz. These partnerships underscore a multidisciplinary approach spanning molecular to clinical research perspectives.

Best Publications

  • Glutaminolysis and Transferrin Regulate Ferroptosis.

    Minghui Gao;Prashant Monian;Nosirudeen Quadri;Ravichandran Ramasamy

  • Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation

    Ravichandran Ramasamy;Susan J. Vannucci;Shirley Shi Du Yan;Kevan Herold

  • Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.

    Shi Fang Yan;Ravichandran Ramasamy;Yoshifumi Naka;Ann Marie Schmidt

  • Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications.

    Ravichandran Ramasamy;Shi Fang Yan;Ann Marie Schmidt

  • Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.

    Shi Fang Yan;Ravichandran Ramasamy;Ann Marie Schmidt

  • D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease

    Kim Tieu;Celine Perier;Casper Caspersen;Peter Teismann

  • The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.

    Shi Fang Yan;Ravichandran Ramasamy;Ann Marie Schmidt

  • Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice

    Evis Harja;De-xiu Bu;Barry I. Hudson;Jong Sun Chang

  • RAGE: therapeutic target and biomarker of the inflammatory response―the evidence mounts

    Ravichandran Ramasamy;Shi Fang Yan;Ann Marie Schmidt

  • Glucose, Glycation, and RAGE: Implications for Amplification of Cellular Dysfunction in Diabetic Nephropathy

    Thoralf Wendt;Nozomu Tanji;Jiancheng Guo;Barry I. Hudson

  • Receptor for Advanced-Glycation End Products Key Modulator of Myocardial Ischemic Injury

    Loredana G. Bucciarelli;Michiyo Kaneko;Radha Ananthakrishnan;Evis Harja

  • Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging.

    Ravichandran Ramasamy;Shi Fang Yan;Vivette D'Agati;Ann Marie Schmidt

  • Acute Elevations of Plasma Asymmetric Dimethylarginine and Impaired Endothelial Function in Response to a High-Fat Meal in Patients With Type 2 Diabetes

    Ali Fard;Catherine H. Tuck;Joshua A. Donis;Robert Sciacca

  • Receptor for AGE (RAGE) and its ligands—cast into leading roles in diabetes and the inflammatory response

    Shi Fang Yan;Ravichandran Ramasamy;Ann Marie Schmidt

  • Insulin Resistance: Metabolic Mechanisms and Consequences in the Heart

    E. Dale Abel;Karen M. O’Shea;Ravichandran Ramasamy

  • Radical Roles for RAGE in the Pathogenesis of Oxidative Stress in Cardiovascular Diseases and Beyond

    Gurdip Daffu;Carmen Hurtado Del Pozo;Karen M. O'Shea;Radha Ananthakrishnan

  • Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain

    David J. Pinsky;M. Johan Broekman;Jacques J. Peschon;Kim L. Stocking

  • Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders

    Barry I Hudson;Loredana G Bucciarelli;Thoralf Wendt;Taichi Sakaguchi

  • Soluble RAGE: Therapy and biomarker in unraveling the RAGE axis in chronic disease and aging

    Shi Fang Yan;Ravichandran Ramasamy;Ann Marie Schmidt

  • RAGE Regulates the Metabolic and Inflammatory Response to High-Fat Feeding in Mice

    Fei Song;Carmen Hurtado del Pozo;Rosa Rosario;Yu Shan Zou

Frequent Co-Authors

Ann Marie Schmidt
Ann Marie Schmidt New York University
Shi Fang Yan
Shi Fang Yan Columbia University
Vivette D. D'Agati
Vivette D. D'Agati Columbia University
Shi Du Yan
Shi Du Yan Columbia University
Richard A. Friedman
Richard A. Friedman Columbia University
Yoshifumi Naka
Yoshifumi Naka Columbia University
Ira J. Goldberg
Ira J. Goldberg New York University
Kevan C. Herold
Kevan C. Herold Yale University
Huilin Li
Huilin Li Van Andel Institute
Shunichi Homma
Shunichi Homma Columbia University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in the healthcare field but seeking flexible study options or alternative career paths beyond the traditional MD, there are many accredited online programs to consider. These pathways can lead to rewarding roles in both clinical and administrative settings.

If you are passionate about mental health, pmhnp online programs prepare you to become a licensed psychiatric mental health nurse practitioner. These programs offer an accelerated route to advanced practice, often accommodating working nurses.

For those drawn to leadership, an online master of health administration can equip you for management positions in hospitals and clinics. There are also cheapest mha programs for cost-conscious students seeking top value.

Nurses aiming for the highest level of clinical practice may consider the cheapest online dnp programs, providing advanced skills for leadership and evidence-based care. Whichever pathway you choose, these online degrees enable flexible education to help you achieve your professional healthcare goals.

Best Scientists Citing Ravichandran Ramasamy

Trending Scientists